PNS260 INCLUSION OF NEW STRATEGIES IN THE UK'S CANCER DRUG FUND: WHAT WAS DECIDED IN FRANCE?

Abstract

Authors

M. Trancart C. Almond W. Sullivan

Full Text Cite This Article
Back to Volume 22, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×